Related Experiment Videos
Integration of formulary systems with centralized pharmaceutical procurement
E B Smith1, S M Hope, S K Halstead
1Navajo Area Indian Health Service, Window Rock, AZ 86515.
Summary
Centralized pharmaceutical procurement in the Indian Health Service reduced drug costs and improved drug use information. Two integration models achieved consensus on cost-effective, high-quality therapeutics across multiple facilities.
Area of Science:
- Health Services Research
- Pharmaceutical Policy
- Public Health Administration
Background:
- The Indian Health Service (IHS) operates numerous hospitals and ambulatory centers, necessitating efficient pharmaceutical management.
- Integrating formularies with group purchasing and supply systems is crucial for cost-effectiveness and quality of care.
- Previous models for multi-facility pharmaceutical management within IHS required evaluation.
Purpose of the Study:
- To describe the integration of formularies with pharmaceutical group purchasing and supply systems within the IHS.
- To present and compare two distinct models of system integration implemented across multiple IHS facilities.
- To evaluate the impact of these integrated systems on drug costs and information on drug use.
Main Methods:
- Two models of integrating formularies and pharmaceutical procurement systems were implemented across IHS facilities.
- Model 1: Separate Pharmacy and Therapeutics (P & T) Committees and formularies per facility, with centralized drug procurement.
- Model 2: A central P & T Committee and formulary for all facilities, supplemented by facility-level P & T Committees.
Main Results:
- Both centralized procurement models led to decreased drug costs across the multifacility systems.
- Integrated systems resulted in increased information regarding drug utilization within the facilities.
- Staff consensus was achieved on selecting high-quality therapeutics in a cost-conscious manner under both models.
Conclusions:
- Centralized pharmaceutical procurement models are effective in reducing costs and enhancing drug use data within the IHS.
- The described integration strategies facilitate consensus on formulary selection for optimal therapeutic and economic outcomes.
- These approaches support the provision of quality therapeutics in a cost-effective environment for diverse healthcare settings.